Study of TJ0113 capsules for age-related hearing loss
Treatments studied
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This trial tests a new oral medication, TJ0113, to see if it is safe and can help improve hearing in older adults with gradual hearing loss due to aging. It is for people who have not used hearing aids or have stopped using them for three months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 65 and 80 years old.
- You have hearing loss in both ears that is moderate to severe and has been present for more than 3 months.
- You have not used hearing aids, or if you have, you stopped using them at least 3 months ago.
- You do not have a history of ear infections, ear surgery, or other ear conditions (like Meniere's disease).
- You are not a musician, conductor, or someone regularly exposed to loud noise.
- You do not have serious heart, liver, kidney, or other medical conditions, and you are not taking certain medications for dementia or depression.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (DX243) to see if it is safe and well-tolerated in people with hearing difficulties, especially trouble hearing speech in noisy environments. The goal is to understand how the body processes this medicine and whether it might help improve hearing.
This study follows older adults who have age-related hearing loss to see whether wearing hearing aids helps protect thinking and memory over time. You may be included if your hearing loss is the type that hearing aids can usually improve and if your thinking test scores suggest mild cognitive difficulties.
This trial compares two types of hearing aids (one made in China, one imported) to see which works better for age-related hearing loss. You might benefit if you have moderate to severe hearing loss and are willing to test both devices.
This study is developing a system to evaluate and improve hearing for people with congenital hearing loss. It compares participants who have hearing loss (and have used hearing aids, cochlear implants, or gene therapy) with healthy controls, to better understand and treat hearing challenges.
This study tests a new drug called TRTL-913 to see if it is safe and helps reduce tinnitus (ringing in the ears). It has two parts: one for healthy volunteers and one for people with tinnitus.
This trial tests an oral capsule called 'Inner Ear Support' to see if it helps people with sudden hearing loss. It is for adults who have severe, sudden hearing loss and start treatment quickly.
Hear when a new Age-related Hearing Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.